chitosan has been researched along with Labyrinth Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bezpalko, O; Bur, A; Chi, FL; Gu, R; Han, Z; Lajud, SA; Li, D; Nagda, DA; O'Malley, BW; Sanyal, S | 1 |
Abuzeid, W; Jiang, H; Li, D; O'Malley, BW; Oe, T; Paulson, DP | 1 |
2 other study(ies) available for chitosan and Labyrinth Diseases
Article | Year |
---|---|
A regulated delivery system for inner ear drug application.
Topics: Animals; Anti-Bacterial Agents; Blotting, Western; Chitosan; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Ear, Inner; Electrophoresis, Polyacrylamide Gel; Escherichia coli; Female; Gentamicins; Glycerophosphates; Glycoside Hydrolases; Hydrogels; Labyrinth Diseases; Male; Mice; Mice, Inbred Strains; Microscopy, Fluorescence; Models, Biological; Plasmids; Staphylococcus aureus; Tissue Distribution | 2013 |
A novel controlled local drug delivery system for inner ear disease.
Topics: Absorbable Implants; Animals; Anti-Inflammatory Agents; Auditory Threshold; Biocompatible Materials; Chitosan; Delayed-Action Preparations; Dexamethasone; Drug Delivery Systems; Evoked Potentials, Auditory, Brain Stem; Glucocorticoids; Glycerophosphates; Hearing; Hydrogel, Polyethylene Glycol Dimethacrylate; Labyrinth Diseases; Materials Testing; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Models, Animal; Oval Window, Ear; Perilymph; Round Window, Ear | 2008 |